You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Tumor Hypoxia

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Head and Neck Squamous Cell Carcinoma, Brain Metastases Trial in Nashville (Magnetic Resonance Imaging (MRI), Positron Emission

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Brain Metastases
  • Magnetic Resonance Imaging (MRI)
  • +2 more
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Aug 10, 2023

Brain Cancer Trial in Salt Lake City ([18F]fluoro-2-deoxy-D-glucose (FDG),

Recruiting
  • Brain Cancer
  • [18F]fluoro-2-deoxy-D-glucose (FDG)
  • +3 more
  • Salt Lake City, Utah
    Huntsman Cancer Institute
Jan 3, 2023

Prostate Cancer, Prostate Tumor Trial in Winston-Salem (Blood draws, Magnetic resonance imaging (MRI))

Withdrawn
  • Prostate Cancer
  • Prostate Tumor
  • Blood draws
  • Magnetic resonance imaging (MRI)
  • Winston-Salem, North Carolina
    Wake Forest Baptist Comprehensive Cancer Center
Nov 17, 2021

Head Neck Cancer Trial in New York (PET/CT Imaging)

Withdrawn
  • Head and Neck Cancer
  • PET/CT Imaging
  • New York, New York
    Citigroup Biomedical Imaging Center
Dec 21, 2021

Imaging Tumor Hypoxia With 18F-EF5 PET in Recurrent or

Terminated
  • Ovarian Cancer
  • Ovarian Neoplasms
  • 18F-EF5 PET/CT scan
  • Optional biopsy
  • Vancouver, British Columbia, Canada
    BC Cancer Agency - Vancouver Centre
Feb 2, 2022

Head Neck Cancer Trial in Turku (PET-MRI)

Recruiting
  • Head and Neck Cancer
  • PET-MRI
  • Turku, G102881, Finland
    Turku University Hospital
Feb 8, 2022

Non-Small-Cell-Lung Cancer (NSCLC) Trial in New York (18F-FMISO, PET/CT)

Active, not recruiting
  • Non-Small-Cell-Lung Cancer (NSCLC)
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 3, 2022

Melanoma, NSCLC, Hepatocellular Carcinoma Trial in Pittsburgh (Nivolumab or Pembrolizumab (dependent upon approved indication),

Recruiting
  • Melanoma
  • +7 more
  • Nivolumab or Pembrolizumab (dependent upon approved indication)
  • +2 more
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Feb 10, 2022

Bystander Effect, Abscopal Effect, Unresectable Malignant Solid Tumor Trial in Klagenfurt (SBRT-PATHY (SBRT-based PArtial Tumor

Recruiting
  • Bystander Effect
  • +3 more
  • SBRT-PATHY (SBRT-based PArtial Tumor irradiation targeting HYpoxic segment)
  • Klagenfurt, Kaernten, Austria
    KABEG Klinikum Klagenfurt, Institute for Radiation Oncology
Apr 6, 2022

Anaesthetists in Changing Ventilation Strategies During

Not yet recruiting
  • ENT Tumor
    • Besançon, Franche Comté, France
      Centre Hospitalier Universitaire de Besançon
    Oct 26, 2022

    Brain Tumor, Metabolic Disturbance, Inflammatory Response Trial in Thessaloniki (Dexmedetomidine, Normal saline)

    Completed
    • Brain Tumor
    • +3 more
    • Thessaloniki, Greece
      AHEPA University Hospital
    Feb 14, 2022

    Acquired Brain Injury, Stroke/ Cerebrovascular Accident (Ischemic or Hemorrhagic), Brain Tumor (After Recovery) Trial in

    Recruiting
    • Acquired Brain Injury
    • +5 more
    • Dialectical Behavior Therapy and Radically Open dialectical behavior therapy
    • Illkirch-Graffenstaden, France
      Service EMOI-TC - Pôle de MPR Institut Universitaire de Réadapta
    May 23, 2022

    Tumor Hypoxia of Head-and-neck Cancer Underwent Radiation

    Completed
    • Head and Neck Neoplasms
      • Dresden, Germany
        Department of Nuclear Medicine
      Feb 28, 2020

      Novel Hypoxia Imaging for Head and Neck Cancer: Imaging

      Not yet recruiting
      • Head and Neck Cancer
      • +3 more
      • [18F]MISO-PET/CT
      • (no location specified)
      Oct 29, 2023

      Prostate Cancer Trial in Copenhagen (High Intensity Interval Training bout)

      Completed
      • Prostate Cancer
      • High Intensity Interval Training bout
      • Copenhagen, Denmark
        Center for Physical Activity Research, Copenhagen University Hos
      Dec 12, 2019

      Intracranial Tumor Trial in Portland (Magnetic Resonance Imaging, Oxygen Therapy)

      Recruiting
      • Intracranial Neoplasm
      • Magnetic Resonance Imaging
      • Oxygen Therapy
      • Portland, Oregon
        OHSU Knight Cancer Institute
      Jun 6, 2023

      Perfusion and Hypoxia Evaluation in Tumors Using 18F-FDG PET/CT

      Unknown status
      • Perfusion and Hypoxia
      • 18F-FDG PET/CT initial-time imaging
      • 18F-FDG PET/CT balanced-time imaging
      • Harbin, Heil, China
        Yingying Sun
      Feb 20, 2020

      Cervix Cancer Trial in Toronto (18F-Fluoroazomycin Arabinoside (18F-FAZA))

      Active, not recruiting
      • Cervix Cancer
      • 18F-Fluoroazomycin Arabinoside (18F-FAZA)
      • Toronto, Ontario, Canada
        Princess Margaret Hospital
      Oct 21, 2022

      MRI Guided Radiotherapy and Radiobiological Data: ISRAR Database

      Not yet recruiting
      • Prostate Cancer
      • +4 more
      • 3 MRI sequences (T2*, IVIM and Multi Echo-Gradient), without injection, are performed
      • (no location specified)
      Sep 18, 2023

      Brain Damage, Hypoxic, Stroke, Brain Tumor Trial in Seongnam (Extracorporeal shockwave therapy)

      Recruiting
      • Brain Damage, Hypoxic
      • +3 more
      • Extracorporeal shockwave therapy
      • Seongnam, Korea, Republic of
        Department of Rehabilitation Medicine, CHA Bundang Medical Cente
      Nov 2, 2020

      Head and Neck Tumors, Recurrence Tumor Trial in Berlin (Moderate whole body hyperthermia using water-filtered IR-A-radiation)

      Completed
      • Head and Neck Neoplasms
      • Recurrence Tumor
      • Moderate whole body hyperthermia using water-filtered IR-A-radiation
      • Berlin, Germany
        Klinik für Radioonkologie und Strahlentherapie
      May 4, 2020

      Lung Cancer Trial in Toronto (18-F-FAZA)

      Recruiting
      • Lung Cancer
      • 18-F-FAZA
      • Toronto, Ontario, Canada
        University Health Network, Princess Margaret Cancer Centre
      Oct 6, 2022

      Hypoxia-Induced Prostate Cancer Aggressiveness

      Active, not recruiting
      • Prostatic Neoplasms
      • +2 more
        • Oslo, Norway
          Oslo University Hospital
        Jun 16, 2022

        Solid Tumor Trial (CP-506, Carboplatin, Immune checkpoint inhibitor)

        Not yet recruiting
        • Unspecified Adult Solid Tumor, Protocol Specific
        • (no location specified)
        Jun 23, 2022

        HER2 Positive Advanced Solid Tumors Trial (HypoSti.CAR-HER2 T cells, Albumin-bound paclitaxel, Cyclophosphamide)

        Not yet recruiting
        • HER2 Positive Advanced Solid Tumors
        • HypoSti.CAR-HER2 T cells
        • +2 more
        • (no location specified)
        Jan 12, 2023